1. Home
  2. SILO vs PAVM Comparison

SILO vs PAVM Comparison

Compare SILO & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • PAVM
  • Stock Information
  • Founded
  • SILO 2010
  • PAVM 2014
  • Country
  • SILO United States
  • PAVM United States
  • Employees
  • SILO N/A
  • PAVM N/A
  • Industry
  • SILO Apparel
  • PAVM Medical/Dental Instruments
  • Sector
  • SILO Consumer Discretionary
  • PAVM Health Care
  • Exchange
  • SILO Nasdaq
  • PAVM Nasdaq
  • Market Cap
  • SILO 4.3M
  • PAVM 12.0M
  • IPO Year
  • SILO N/A
  • PAVM 2016
  • Fundamental
  • Price
  • SILO $0.62
  • PAVM $0.61
  • Analyst Decision
  • SILO
  • PAVM Strong Buy
  • Analyst Count
  • SILO 0
  • PAVM 1
  • Target Price
  • SILO N/A
  • PAVM $19.00
  • AVG Volume (30 Days)
  • SILO 2.2M
  • PAVM 158.5K
  • Earning Date
  • SILO 08-12-2025
  • PAVM 08-11-2025
  • Dividend Yield
  • SILO N/A
  • PAVM N/A
  • EPS Growth
  • SILO N/A
  • PAVM N/A
  • EPS
  • SILO N/A
  • PAVM 0.96
  • Revenue
  • SILO $72,102.00
  • PAVM $1,993,000.00
  • Revenue This Year
  • SILO $1.86
  • PAVM N/A
  • Revenue Next Year
  • SILO N/A
  • PAVM $455.63
  • P/E Ratio
  • SILO N/A
  • PAVM $0.64
  • Revenue Growth
  • SILO N/A
  • PAVM N/A
  • 52 Week Low
  • SILO $0.41
  • PAVM $0.55
  • 52 Week High
  • SILO $4.50
  • PAVM $1.90
  • Technical
  • Relative Strength Index (RSI)
  • SILO 47.67
  • PAVM 43.11
  • Support Level
  • SILO $0.60
  • PAVM $0.59
  • Resistance Level
  • SILO $0.66
  • PAVM $0.63
  • Average True Range (ATR)
  • SILO 0.04
  • PAVM 0.04
  • MACD
  • SILO 0.01
  • PAVM -0.00
  • Stochastic Oscillator
  • SILO 46.06
  • PAVM 27.06

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About PAVM PAVmed Inc.

PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.

Share on Social Networks: